1-3 of 3
Robyn Rodwell
Close
Sort by
Journal Articles

Significant Reduction of BCR-ABL Transcripts after Switching to Imatinib Therapy in Patients with CML and Complete or Near-Complete Cytogenetic Responses to Interferon-Alpha (IFN).

Susan Branford, Timothy Hughes, Steven Stylian, Anthony P. Schwarer, Chris Arthur, Robin Filshie, Susan Moreton, Robyn Rodwell, Nancy Guzzo-Pernell, Deb Taylor, Jenny Larson, Rachel Koelmayer, Alvin Milner, Kevin Lynch, Kerry McDonald Taylor
Journal: Blood
Blood (2006) 108 (11): 2142.
https://doi.org/10.1182/blood.V108.11.2142.2142
Published: 2006
Journal Articles

Granulocyte-colony stimulating factor increases CD123 hi blood dendritic cells with altered CD62L and CCR7 expression

Clinical Trials & Observations Brief Report
Slavica Vuckovic, Min Kim, Dailal Khalil, Cameron J. Turtle, Georgina V. Crosbie, Noel Williams, Len Brown, Katrina Williams, Cathryn Kelly, Penny Stravos, Robyn Rodwell, Geoff R. Hill, Susan Wright, Kerry Taylor, Devinder Gill, Paula Marlton, Ken Bradstock, Derek N. J. Hart
Journal: Blood
Blood (2003) 101 (6): 2314–2317.
https://doi.org/10.1182/blood-2002-03-0973
Published: 2003
Journal Articles

The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins

Asuman Demiroglu, E. Joanna Steer, Carol Heath, Kerry Taylor, Mark Bentley, Steven L. Allen, Prasad Koduru, Judith P. Brody, Geoffrey Hawson, Robyn Rodwell, Mary-Lou Doody, Fernando Carnicero, Andreas Reiter, John M. Goldman, Junia V. Melo, Nicholas C. P. Cross
Journal: Blood
Blood (2001) 98 (13): 3778–3783.
https://doi.org/10.1182/blood.V98.13.3778
Published: 2001